BE691049A - - Google Patents

Info

Publication number
BE691049A
BE691049A BE691049DA BE691049A BE 691049 A BE691049 A BE 691049A BE 691049D A BE691049D A BE 691049DA BE 691049 A BE691049 A BE 691049A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE691049A publication Critical patent/BE691049A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F23COMBUSTION APPARATUS; COMBUSTION PROCESSES
    • F23KFEEDING FUEL TO COMBUSTION APPARATUS
    • F23K3/00Feeding or distributing of lump or pulverulent fuel to combustion apparatus
    • F23K3/10Under-feed arrangements
    • F23K3/14Under-feed arrangements feeding by screw

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Combustion & Propulsion (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE691049D 1965-12-13 1966-12-12 BE691049A (env)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51359965A 1965-12-13 1965-12-13
US513553A US3412193A (en) 1965-12-13 1965-12-13 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility

Publications (1)

Publication Number Publication Date
BE691049A true BE691049A (env) 1967-05-16

Family

ID=27057915

Family Applications (1)

Application Number Title Priority Date Filing Date
BE691049D BE691049A (env) 1965-12-13 1966-12-12

Country Status (7)

Country Link
US (1) US3412193A (env)
BE (1) BE691049A (env)
CH (1) CH476001A (env)
DE (1) DE1620057C3 (env)
FR (1) FR1504326A (env)
GB (1) GB1129393A (env)
NL (1) NL6617500A (env)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3597429A (en) * 1968-02-15 1971-08-03 Miles Lab Derivatives of tetrazolyl alkanoic acids
GB1265866A (env) * 1968-08-23 1972-03-08
US3884922A (en) * 1969-07-31 1975-05-20 Yoshitomi Pharmaceutical 11-(4-Pyridylalkyl-piperazino)-dibenzothiazepines
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US5114942A (en) * 1989-03-31 1992-05-19 Yale University Treating habit disorders
US5059600A (en) * 1989-03-31 1991-10-22 Yale University Treating habit disorders
US5223497A (en) * 1989-03-31 1993-06-29 Yale University Treating habit disorders
AU736026B2 (en) * 1997-12-17 2001-07-26 Merck & Co., Inc. Integrin receptor antagonists
US6890919B2 (en) * 2001-06-26 2005-05-10 Shitij Kapur Atypical antipsychotic agents having low affinity for the D2 receptor
US7388954B2 (en) * 2002-06-24 2008-06-17 Freescale Semiconductor, Inc. Method and apparatus for tone indication
AU2003290079A1 (en) * 2002-12-20 2004-07-14 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
AU2004206931A1 (en) * 2003-01-23 2004-08-05 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine to treat human neuropsychiatric disease
JP4767850B2 (ja) 2003-08-20 2011-09-07 エミスフィアー テクノロジーズ インコーポレイテッド グルカゴン様ペプチド(glp)−1化合物またはメラノコルチン4受容体(mc4)アゴニストペプチドの経口デリバリーのための化合物、方法および製剤
CN100398536C (zh) 2003-08-20 2008-07-02 爱密斯菲尔科技公司 用于口服传递glp-1化合物或mc4激动剂肽的化合物、方法和制剂
CA2550735A1 (en) 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
CN1950346A (zh) * 2004-04-01 2007-04-18 阿卡蒂亚药品公司 N-去甲基氯氮平的晶形
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
ME01516B (me) 2008-06-20 2014-04-20 Astrazeneca Ab DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA

Also Published As

Publication number Publication date
FR1504326A (fr) 1967-12-01
NL6617500A (env) 1967-06-14
US3412193A (en) 1968-11-19
DE1620057C3 (de) 1978-06-08
DE1620057A1 (de) 1970-03-19
DE1620057B2 (de) 1977-10-06
CH476001A (de) 1969-07-31
GB1129393A (en) 1968-10-02

Similar Documents

Publication Publication Date Title
JPS4516087Y1 (env)
JPS4429470Y1 (env)
JPS432807Y1 (env)
JPS435107Y1 (env)
JPS4222386Y1 (env)
CS149861B1 (env)
BE664290A (env)
BE672700A (env)
BE673199A (env)
BE669235A (env)
BE675379A (env)
BE666453A (env)
BE675028A (env)
NL6517183A (env)
NL6617500A (env)
BE672809A (env)
BE672016A (env)
BE667827A (env)
BE666888A (env)
BE671857A (env)
BE675805A (env)
SE316859B (env)
BE674761A (env)
NL6507944A (env)
BE674919A (env)